ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,358Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1313

$721K Total Retail Price of All Prescriptions

Rank: 71 out of 1313

657 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Maryland
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Maryland
METOPROLOL TARTRATE 666 624 146 1 7
HYDROCODONE-ACETAMINOPHEN 546 508 90 S3 2 23
FUROSEMIDE 504 441 109 3 6
LEVOTHYROXINE SODIUM 489 465 115 4 3
POTASSIUM CHLORIDE 393 354 65 5 21
LISINOPRIL 386 329 102 6 2
OMEPRAZOLE 368 348 101 7 8
AMLODIPINE BESYLATE 362 357* 88 8 1
LORAZEPAM 349 331 64 B 9 30
SIMVASTATIN 311 276 81 10 5
ALBUTEROL SULFATE 297 256 24 11 101
METFORMIN HCL 257 241 71 12 9
TRAMADOL HCL 254 225 60 13 15
IPRATROPIUM BROMIDE 247 213 24 14 143
CITALOPRAM HBR 240 235* 49 15 31
JANTOVEN 233 215 17 16 59
ATORVASTATIN CALCIUM 207 202* 50 17 4
CLOPIDOGREL 193 179 43 18 18
ALPRAZOLAM 184 137 70 B 19 25
DONEPEZIL HCL 184 172 32 19 24
GABAPENTIN 180 156 44 21 19
LOSARTAN POTASSIUM 168 163* 36 22 12
HYDROCHLOROTHIAZIDE 166 142 54 23 11
ZOLPIDEM TARTRATE 163 134 54 24 28
RISPERIDONE 155 155 23 A 25 50
NAMENDA 145 134 21 26 33
SERTRALINE HCL 143 120 30 27 20
NITROGLYCERIN PATCH 143 138* 27 27 141
PANTOPRAZOLE SODIUM 142 116 41 29 17
LANTUS 134 112 25 30 52
QUETIAPINE FUMARATE 131 113 16 A 31 46
SPIRONOLACTONE 129 124* 26 32 81
WARFARIN SODIUM 126 110 44 33 13
ESCITALOPRAM OXALATE 123 106 23 34 42
NYSTATIN-TRIAMCINOLONE 121 116* 31 35 212
NOVOFINE AUTOCOVER 119 114* 20 36 181
POLYETHYLENE GLYCOL 3350 109 104* 18 37 60
ENALAPRIL MALEATE 101 96* 29 38 92
TAMIFLU 99 94* 98 39 200
GLIPIZIDE 97 86 26 40 39
TAMSULOSIN HCL 94 94 22 41 27
PRAVASTATIN SODIUM 92 92 25 42 10
METOPROLOL SUCCINATE 90 85* 24 43 14
RANITIDINE HCL 89 84* 23 44 29
NOVOLOG FLEXPEN 83 78* 30 45 149
DIGOXIN 80 75* 20 46 153
ATENOLOL 80 75* 24 46 16
TRAZODONE HCL 77 60 18 48 35
OXYCODONE-ACETAMINOPHEN 77 58 28 S2 48 54
ROPINIROLE HCL 76 63 14 50 135
ALLOPURINOL 74 74 19 51 45
SPIRIVA 74 58 14 51 67
LOVASTATIN 73 73 16 53 38
CYMBALTA 73 68* 15 53 55
FAMOTIDINE* 71 66* 11 55 84
FENTANYL 70 <11 <11 S2 56 110
NYAMYC 70 <11 <11 56 264
ENULOSE 66 <11 <11 58 165
NEXIUM 64 40 14 59 44
MIRTAZAPINE 64 <11 <11 59 22
QUINAPRIL HCL 64 64 19 59 184
ISOSORBIDE MONONITRATE ER 63 <11 <11 62 66
AZITHROMYCIN 61 56* 31 63 49
AMOXICILLIN 57 43 33 64 120
TRIAMCINOLONE ACETONIDE 57 52* 26 64 113
FLUOXETINE HCL 57 52* 16 64 86
SYNTHROID 57 52* 19 64 70
CRESTOR 56 51* 14 68 26
VENLAFAXINE HCL ER 55 <11 <11 69 128
CLONAZEPAM 53 41 19 B 70 62
RAMIPRIL 53 48* 17 70 98
PAROXETINE HCL 51 <11 <11 72 75
NITROFURANTOIN* 50 50 13 73 276
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.